Purchase Order 75N93025P00056
Award Date
11/1/24
Potential Completion Date
7/4/25
Potential Value
$33K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $93,525.44 contract provides a 12-month silver support plan for two NextSeq 2000 sequencing systems. No set-aside was used. Illumina is a manufacturer and provider of genomic analysis instruments and reagents, and has previously received prime federal contracts and sub-awards from the NIH, CDC,...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Illumina, Inc. for a service agreement renewal and co-term for a NextSeq 2000 Silver Support Plan. The potential value of the award is $29,158.67, and the period of performance runs through July 4, 2024. Illumina is a for-profit manufacturer that has previously provided a range of sequencing systems, reagents, and support services to federal...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Illumina, Inc. for a service agreement for a NextSeq 2000 sequencing system. The total ceiling value of the contract is $48,209.00 and it has an ultimate completion date of December 15, 2025. This contract does not have a set-aside designation. Illumina is a manufacturer of genomic sequencing instruments and reagents, and...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for a NextSeq 2000 Silver Support Plan and Preventive Maintenance with a total ceiling value of $23,717.81. The award does not utilize any set-aside designations. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has received prior prime federal contract and sub-grant awards...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a NEXTSEQ 2000 SILVER SUPPORT PLAN. The potential value of the contract is $48,209.00, with a completion date of April 2, 2025. This contract is not set aside and is for the provision of sequencing and array-based solutions to support genomic analysis and life science research. Illumina, a for-profit...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract provides a MiSeq Silver Support Plan with a ceiling value of $13,250.00 and an ultimate completion date of January 2, 2021. Illumina has a long history of providing sequencing systems and related products and services to support research and diagnostics across...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc. for an Illumina Service Contract. The contract has a ceiling value of $72,973.00 and a period of performance through February 28, 2026. Illumina, a manufacturer of genomic sequencing and analysis instruments and reagents, will provide maintenance and support services for NIAID's Illumina sequencing systems, including NextSeq,...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a renewal service agreement to support two Illumina NextSeq sequencing systems. The contract has a ceiling value of $74,756.41 and a period of performance through March 20, 2026. There is no set-aside designation for this award. Illumina is a manufacturer of genomic sequencing...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $24,999 contract is for a NEXTSEQ 2000 BRONZE SUPPORT PLAN (AMBIS 2259765) with a performance period through July 11, 2026. The contract does not utilize any set-aside designation. Illumina has been awarded numerous federal contracts and grants by agencies...
This is a $48,209 firm fixed price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. The contract provides a NEXT SEQ 2000 SILVER SUPPORT PLAN with a completion date of September 12, 2025. Illumina, a for-profit manufacturer of genomic sequencing and analysis equipment and reagents, has previously received other prime federal contracts and subcontracts from...